Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Journal of Personalized Medicine
|
June 25, 2025
Morphology of Macular Neovascularization in Age-Related Macular Degeneration Influences Treatment Requirement and Visual Outcome After 1 Year
Michael Grün, Kai Rothaus, Martin Ziegler, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
August 4, 2022
Impact of the COVID 19 Pandemic on Treatment of nAMD via a Portal-Based Collaboration
Kai Rothaus, Kristina Kintzinger, Britta Heimes-Bussmann, et al.
Diagnostics (Basel, Switzerland)
|
May 1, 2025
The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal Analysis
Michael Grün, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie
|
July 3, 2026
[Real-world experience with aflibercept 8 mg for treatment of neovascular age-related macular degeneration after 12 months]
Michael Grün, Kai Rothaus, Alexander Beger, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
September 13, 2017
[Exudative AMD in OCT Angiography]
Marie-Louise Farecki, Matthias Gutfleisch, Henrik Faatz, et al.
BMJ Open Ophthalmology
|
January 8, 2020
Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment
Henrik Faatz, Marie-Louise Farecki, Kai Rothaus, et al.
Die Ophthalmologie
|
May 29, 2024
[Vitreomacular traction: diagnostics, natural course, treatment decision and guideline recommendations]
Henrik Faatz, Lars-Olof Hattenbach, Tim U Krohne, et al.
The British Journal of Ophthalmology
|
January 8, 2021
Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2
Stefanie Mueller, Frederic Gunnemann, Kai Rothaus, et al.
Diagnostics (Basel, Switzerland)
|
November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
Henrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
January 29, 2021
Quantification of Early and Intermediate Age-related Macular Degeneration Using OCT "en face" Presentation
Frauke Jürgens, Kai Rothaus, Henrik Faatz, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Journal of Personalized Medicine
|
June 25, 2025
Morphology of Macular Neovascularization in Age-Related Macular Degeneration Influences Treatment Requirement and Visual Outcome After 1 Year
Michael Grün, Kai Rothaus, Martin Ziegler, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
August 4, 2022
Impact of the COVID 19 Pandemic on Treatment of nAMD via a Portal-Based Collaboration
Kai Rothaus, Kristina Kintzinger, Britta Heimes-Bussmann, et al.
Diagnostics (Basel, Switzerland)
|
May 1, 2025
The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal Analysis
Michael Grün, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie
|
July 3, 2026
[Real-world experience with aflibercept 8 mg for treatment of neovascular age-related macular degeneration after 12 months]
Michael Grün, Kai Rothaus, Alexander Beger, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
September 13, 2017
[Exudative AMD in OCT Angiography]
Marie-Louise Farecki, Matthias Gutfleisch, Henrik Faatz, et al.
BMJ Open Ophthalmology
|
January 8, 2020
Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment
Henrik Faatz, Marie-Louise Farecki, Kai Rothaus, et al.
Die Ophthalmologie
|
May 29, 2024
[Vitreomacular traction: diagnostics, natural course, treatment decision and guideline recommendations]
Henrik Faatz, Lars-Olof Hattenbach, Tim U Krohne, et al.
The British Journal of Ophthalmology
|
January 8, 2021
Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2
Stefanie Mueller, Frederic Gunnemann, Kai Rothaus, et al.
Diagnostics (Basel, Switzerland)
|
November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
Henrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
January 29, 2021
Quantification of Early and Intermediate Age-related Macular Degeneration Using OCT "en face" Presentation
Frauke Jürgens, Kai Rothaus, Henrik Faatz, et al.
Page
of 4